Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer
Jennifer A. Morrison(University of Colorado Anschutz Medical Campus), Bryan R. Haugen(University of Colorado Cancer Center)
Cited by 102
Related Papers
Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer
|The Journal of Clinical Endocrinology & Metabolism|2009|65
Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal Subjects
|The Journal of Clinical Endocrinology & Metabolism|2006|53